OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod ...

The FDA granted fast track designation to urcosimod to treat neuropathic corneal pain, according to a press release from Okyo Pharma. Urcosimod, formerly called OK-101, is a “lipid conjugated chemerin ...

How have the wild initial months of Donald Trump’s return to the White House landed on Washington? We asked the people who ...

The Food and Drug Administration is again trying to rehire some staffers who were recently fired amid mass layoffs at the ...

As food companies face pressure to eliminate artificial dyes, experts weigh in on the natural alternatives that could replace ...

The department did not confirm which vaccines the testing would be applied to or how the change would be implemented.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.